Cargando…
MiR-18a and miR-18b are expressed in the stroma of oestrogen receptor alpha negative breast cancers
BACKGROUND: Previously, we have shown that miR-18a and miR-18b gene expression strongly correlates with high proliferation, oestrogen receptor -negativity (ER(−)), cytokeratin 5/6 positivity and basal-like features of breast cancer. METHODS: We investigated the expression and localization of miR-18a...
Autores principales: | Egeland, Nina Gran, Jonsdottir, Kristin, Aure, Miriam Ragle, Sahlberg, Kristine, Kristensen, Vessela N., Cronin-Fenton, Deirdre, Skaland, Ivar, Gudlaugsson, Einar, Baak, Jan P. A., Janssen, Emiel A. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201801/ https://www.ncbi.nlm.nih.gov/pubmed/32370743 http://dx.doi.org/10.1186/s12885-020-06857-7 |
Ejemplares similares
-
miR-101-5p Acts as a Tumor Suppressor in HER2-Positive Breast Cancer Cells and Improves Targeted Therapy
por: Normann, Lisa Svartdal, et al.
Publicado: (2022) -
miRNA normalization enables joint analysis of several datasets to increase sensitivity and to reveal novel miRNAs differentially expressed in breast cancer
por: Ben-Elazar, Shay, et al.
Publicado: (2021) -
Validation of Expression Patterns for Nine miRNAs in 204 Lymph-Node Negative Breast Cancers
por: Jonsdottir, Kristin, et al.
Publicado: (2012) -
Validation study of MARCKSL1 as a prognostic factor in lymph node-negative breast cancer patients
por: Egeland, Nina Gran, et al.
Publicado: (2019) -
Expression of miR-221 and miR-18a in patients with hepatocellular carcinoma and its clinical significance
por: Yun, Jong Hyuk, et al.
Publicado: (2022)